Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.
Schetelig, Johannes Chevallier, Patrice van Gelder, Michel Hoek, Jennifer Hermine, Olivier Chakraverty, Ronjon Browne, Paul Milpied, Noel Malagola, Michele Socié, Gerard
Schetelig, Johannes
Chevallier, Patrice
van Gelder, Michel
Hoek, Jennifer
Hermine, Olivier
Chakraverty, Ronjon
Browne, Paul
Milpied, Noel
Malagola, Michele
Socié, Gerard
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2022-02
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
No abstract available
Citation
Schetelig J, Chevallier P, van Gelder M, Hoek J, Hermine O, Chakraverty R, Browne P, Milpied N, Malagola M, Socié G, Delgado J, Deconinck E, Damaj G, Maury S, Beelen D, Quoc SN, Shankara P, Brecht A, Mayer J, Hunault-Berger M, Bittenbring J, Thieblemont C, Lepretre S, Baldauf H, de Wreede LC, Tournilhac O, Yakoub-Agha I, Kröger N, Dreger P. Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party. Bone Marrow Transplant. 2022 Feb;57(2):330. doi: 10.1038/s41409-021-01516-2. Erratum for: Bone Marrow Transplant. 2021 Mar;56(3):605-613. doi: 10.1038/s41409-020-01069-w
Type
Correspondence